Interaction Between Air Pollution, Pollens and Allergic Rhinitis
NCT ID: NCT05007327
Last Updated: 2023-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1215 participants
OBSERVATIONAL
2021-06-22
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In Europe, more than 150 million people suffer from allergic rhinitis and more than 25 million suffer from asthma. About 30% have uncontrolled rhinitis during exposure to allergens. The impact of allergic diseases on work productivity is estimated to be between 30 and 50 billion € per year in the EU.
Studies show that pollution can play a role in the amplification of the response to inhaled pollen allergens by inducing morphological and functional modifications of nasal and bronchial epithelia, but also by inducing structural modifications of allergenic molecules. However, although data show that the symptoms of AR are aggravated by exposure to air pollution, this effect is not observed for all pollens.
The study area is very exposed to pollens (with a significant presence of cypress pollen) and air pollution, and presents a prevalence of asthma of 17% while the national average is about 7%.
The aim of this study is to establish, if they exist, links between pollens of various species, air pollution and symptoms of allergic rhinitis. The knowledge of these links will allow public authorities to set up prevention actions, and patients to better manage their allergic rhinitis on a daily basis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study
NCT03776773
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)
NCT00783198
Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients
NCT01295255
Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy In Southern Europe.
NCT03636919
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)
NCT01385371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A communication of the project will be deployed to the citizens in the study area. The recruitment of participants will be done via an internet page accessible to all and presenting the MISTRAL study. Interested citizens can then access the electronic consent platform.
After signing the participation agreement, they will receive a link to download the MASK-air® mobile application (freely available via the Android and Apple stores) and a personal study code, which will allow them to install the application on their smartphone.
Participants will report their symptoms on the MASK-air app on a daily basis. Entry will only take 1 minute/day. This real-life data will be correlated with air pollution and pollen exposure data.
In anticipation of the prevention actions that will be deployed by the public authorities following this study, an analysis of the expectations and needs of the citizens will be carried out among a part of the participants in the form of 4 questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure to pollen and air pollution
For all subjects of the cohort, we will follow exposure to pollen and air pollution.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person suffering from seasonal allergic rhinitis (hay fever, pollen allergy),
* Person with an android and/or IOS smartphone and having the possibility to connect to the internet (via phone subscription or WIFI connection),
* Person agreeing to install the MASK-air application (medical device) on his personal smartphone,
* Person agreeing to activate their GPS when using the MASK-air® application for the study,
* Person having read and understood the information note and having signed their participation agreement prior to any specific study procedure.
Exclusion Criteria
* Person who has difficulty understanding or reading the information note,
* Person planning to spend a significant percentage of time outside the area of interest (e.g., due to frequent business or personal travel),
* Person declaring to be under guardianship, curatorship or safeguard of justice.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MASK-air SAS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Denis Charpin, Prof
Role: PRINCIPAL_INVESTIGATOR
Association pour la Prévention de la Pollution Atmosphérique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Https://Clin.Edop.Fr/Etude-Mistral
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KM00111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.